Flexion Therapeutics (FLXN) Prices 3.6M Share Offering at $18/Sh

November 16, 2016 9:09 AM EST

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Flexion Therapeutics, Inc. (Nasdaq: FLXN) today announced the pricing of an underwritten public offering of 3,600,000 shares of its common stock at a price to the public of $18.00 per share. The gross proceeds from this offering are expected to be approximately $64.8 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Flexion. The offering is expected to close on or about November 21, 2016, subject to customary closing conditions. Flexion has also granted the underwriters a 30-day option to purchase up to 540,000 additional shares of its common stock at the public offering price, less the underwriting discounts and commissions.

Wells Fargo Securities, RBC Capital Markets and BMO Capital Markets are acting as joint book-running managers.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings

Related Entities

BMO Capital, RBC Capital, Wells Fargo

Add Your Comment